nptn-20220725

0001227025-22-000122.txt : 20220725 0001227025-22-000122.hdr.sgml : 20220725 20220725163609 ACCESSION NUMBER: 0001227025-22-000122 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220725 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220725 DATE AS OF CHANGE: 20220725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOPHOTONICS CORP CENTRAL INDEX KEY: 0001227025 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 943253730 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35061 FILM NUMBER: 221103763 BUSINESS ADDRESS: STREET 1: 3081 ZANKER ROAD CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 4082329200 MAIL ADDRESS: STREET 1: 3081 ZANKER ROAD CITY: SAN JOSE STATE: CA ZIP: 95134 8-K 1 nptn-20220725.htm 8-K nptn-20220725

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 25, 2022

NEOPHOTONICS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

001-35061

94-3253730

(State of incorporation)

(Commission File No.)

(IRS Employer Identification No.)

NeoPhotonics Corporation

3081 Zanker Road

San Jose, California 95134

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (408) 232-9200

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class:	Trading symbol(s):	Name of each exchange on which registered:
Common Stock, $0.0025 par value	NPTN	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)


Emerging growth company			☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On July 25, 2022, the Company issued a press release regarding the Company’s financial results for the second quarter ended June 30, 2022. A copy of the Company’s press release is furnished and attached as Exhibit 99.1 to this Form 8-K.

The information contained in this Item 2.02, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and shall not be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.


Exhibit Number			Description

99.1			Press Release issued by NeoPhotonics Corporation on July 2 5 , 2022, regarding the Company’s financial results for the second quarter ended June 30, 2022.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: July 25, 2022	NEOPHOTONICS CORPORATION

	By:	/S/ ELIZABETH EBY
		Elizabeth Eby
		Senior Vice President, Finance and Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-99.1 2 exhibit991_7252022.htm EX-99.1 Document

Exhibit 99.1

NeoPhotonics Reports Second Quarter 2022 Financial Results

•Revenue of $95.0 million represents 46% year-over-year growth over same quarter last year

•Second sequential quarter with 45+% year-over-year growth; first half revenue of $184 million up 46% from same period last year

•$61 million of revenue from products for 400G and above applications, contributing 64% of revenue and representing approximately 105% year-over-year growth.

•GAAP Operating Profit of $6.4 million, up from a loss of $16.3 million in the same period last year on the strength of the 400G product ramp

SAN JOSE, Calif. — July 25, 2022 - NeoPhotonics Corporation (NYSE: NPTN), a leading developer of silicon photonics and advanced hybrid photonic integrated circuit-based lasers, modules and subsystems for bandwidth-intensive, high-speed communications networks, today announced financial results for its second quarter of 2022.

“Our business remains on a strong growth path with revenue of $95 million, 46% above the same quarter last year and also up 46% year-to-date. This was despite ongoing supply chain limitations which had an adverse impact on revenue of approximately $10 million. Our 400G and above products grew approximately 105% year-over-year, and now comprise 64% of total revenue. Our revenue from 400ZR coherent DCO module products to datacenter customers is now in low millions per quarter,” said Tim Jenks, Chairman and CEO of NeoPhotonics. “In addition to 400ZR, we are ramping our 96 Gbaud components and sampling 130 Gbaud for even higher data rate applications. These new component products, together with our ramping 400ZR and CFP2 400G module products, give us confidence in continued growth for the quarters ahead, despite the expected challenges with IC chip supply shortages.”

Mr. Jenks continued, “I would like to thank NeoPhotonics employees for their continued commitment, which has built the Company’s strong technology leadership for high speed over distance applications and has resulted in the Company’s strong performance in the second quarter of 2022.”

Mr. Jenks concluded, “The Lumentum transaction, announced last November, remains on track having been approved by our shareholders and received antitrust clearance from US regulators. We look forward to securing regulatory approval in China and closing the transaction. Our strong quarter with more than 46% year over year revenue growth, GAAP operating profit and significant growth from western customers, reflects our success in pivoting our business following the loss of revenue in 2020 due to Department of Commerce restrictions on certain Chinese customers.”

Second Quarter 2022 Summary

•Revenue of $95.0 million was up 46% year-over-year on growth in 400G and above capable products and up 6% quarter-over-quarter. Supply chain shortages negatively impacted revenue by approximately $10 million in the second quarter. Demand remains strong and chip supply continues to constrain revenue.

•Three customers were greater than 10% of our revenue for the three months ended June 30, 2022 and our top five customers accounted for 83% of our revenue in the quarter versus 77% in the same quarter last year.

Exhibit 99.1

•Gross margin was 34.8%, up nearly 20 percentage points year-over-year on improved factory utilization and up 4.2 percentage points from the prior quarter on meaningful yield improvements.

•Non-GAAP gross margin was 35.2% up from 21.7% in the same quarter last year and 31.2% in the prior quarter.

•Operating expense was $26.7 million, down $3.4 million from Q1’22 on a gain on the sale of our Fremont wafer fab and lower costs related to the sale.

•Non-GAAP operating expense of $24.1 million, down $0.9 million from Q1’22 on lower R&D materials & operating costs of the Fremont site.

•Operating income was $6.4 million, compared to a loss of $2.8 million in Q1’22 and a loss of $16.3 million in Q2’21, driven by the significant improvement in revenue and gross margin.

•Non-GAAP operating income was $9.4 million, compared to a loss of $10.3 million in Q2’21 and a profit of $2.8 million in the prior quarter, a notable turnaround in results.

•Foreign Exchange was a gain of $6.0 million on the appreciation of the U.S. dollar. As a reminder, the foreign exchange impact is largely related to the revaluation of U.S. dollar assets on our overseas books which are stated in their local currency. Beginning this quarter, we will exclude unrealized foreign exchange from our Non-GAAP results, to better focus on our operational results.

•Net earnings per share was $0.17, compared to net loss of $0.34 a year ago and a loss of $0.06 per share in the prior quarter.

•Non-GAAP net income per share was $0.15, compared to a Non-GAAP loss per share of $0.22 a year ago and a Non-GAAP earnings per share of $0.04 in the prior quarter. Excluding the impact of unrealized foreign exchange in the prior quarters, earnings per share was a loss of $0.22 in Q2’21 and an income of $0.05 in Q1’22.

•Adjusted EBITDA was $13.2 million, up from $7.8 million in the prior quarter excluding the impact of unrealized foreign exchange.

•Net Inventory grew $5.8 million from Q1’22, to $66 million, as we increased 400ZR inventories to a total of $20 million to ensure ongoing module supply.

•As of June 30, 2022, cash and cash equivalents, short-term investments and restricted cash totaled $105 million, down approximately $2.0 million from Q1’22. Capital Expenditure was $3 million.

Non-GAAP results in the second quarter of 2022 exclude gains of $5.4 million for unrealized foreign exchange, $1.9 million on the sale of assets, expenses of $2.6 million for stock-based compensation, $2.0 million of merger retention and other acquisition related charges, income tax effect of $1.4 million for Non-GAAP items and $0.2 million of other charges. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release.

NeoPhotonics Product Milestone Achievements

•Products capable of use for 400G and above applications were 64% of revenue in Q2 2022.

•Continued to ramp production of our 400ZR small form factor coherent transceiver modules, reaching low single digit millions in revenue.

•Shipped first samples of 130 Gbaud Coherent Receivers and Modulators for next generation 800G and 1.6T links.

•Conducted webinar outlining the application of NeoPhotonics coherent products and technology to Lidar for Autonomous Vehicles and other remote sensing applications.

Supply Chain Impacts

Exhibit 99.1

Second quarter revenue was approximately $10 million lower than we project it would have been without supply chain constraints. Supply chain impacts in the quarter were primarily shortages of analog and power semiconductors. The Company expects such impacts to continue through 2022.

Non-GAAP and Adjusted EBITDA Measures vs. GAAP Financial Measures

The Company’s non-GAAP and Adjusted EBITDA measures exclude certain GAAP financial measures. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release. These non-GAAP financial measures differ from GAAP measures with the same captions and may differ from non-GAAP financial measures with the same or similar captions that are used by other companies. As such, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.

The Company uses these non-GAAP financial measures to analyze its operating performance and future prospects, develop internal budgets and financial goals, and to facilitate period-to-period comparisons. NeoPhotonics believes that these non-GAAP financial measures reflect an additional way of viewing aspects of its operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.

Conference Call

The Company will not host a conference call regarding the Q2 2022 results.

About NeoPhotonics

NeoPhotonics is a leading developer and manufacturer of lasers and optoelectronic solutions that transmit, receive and switch high-speed digital optical signals for Cloud and hyper-scale data center internet content provider and telecom networks. The Company’s products enable cost-effective, high-speed over distance data transmission and efficient allocation of bandwidth in optical networks. NeoPhotonics maintains headquarters in San Jose, California and ISO 9001:2015 certified engineering and manufacturing facilities in Silicon Valley (USA), Japan and China. For additional information visit www.neophotonics.com.

Notice Regarding Forward-Looking Statements

This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events, including the timing of the proposed transaction, information related to the proposed transaction, and supply chain constraints. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these words or other similar terms or expressions that concern the proposed transaction and our expectations, strategy, plans or intentions regarding it. Forward-looking statements in this communication include, but are not limited to, (i) expectations regarding the timing, completion and expected benefits of the proposed transaction, (ii) expected continued supply chain impacts, plans, objectives and intentions with respect to future operations, customers and the market, and (iii) future growth and profitability. Expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include the risk that the transaction may not be completed in a timely manner or at all; the ability to secure additional regulatory approvals on the terms expected in a timely manner or at all; the effect of the announcement or pendency of the transaction on our business relationships, results of operations and

Exhibit 99.1

business generally; ability to win customer awards; risks that the proposed transaction disrupts current plans and operations; the risk of litigation and/or regulatory actions related to the proposed transaction; disruptions and shortages in supply chains; impact of inflation on our business; potential impacts of the Covid-19 pandemic; changing supply and demand conditions in the industry; and general market, political, economic, and business conditions. The forward-looking statements contained in this communication are also subject to other risks and uncertainties, including those more fully described in filings with the Securities and Exchange Commission ("SEC"), including reports filed on Form 10-K, 10-Q and 8-K and in other filings made by NeoPhotonics with the SEC from time to time and available at www.sec.gov. These forward looking statements are based on current expectations, and are based on NeoPhotonics’ current expectations, which is subject to change.

The parties undertake no obligation to update the information contained in this communication or any other forward-looking statement.

NeoPhotonics Corporation

Condensed Consolidated Balance Sheets (Unaudited)

(In thousands)


	As of
	Jun. 30, 2022		Dec. 31, 2021

ASSETS
Current assets:
Cash and cash equivalents	$	77,079	$	77,833
Short-term investments	27,720		27,675
Restricted cash	38		87
Accounts receivable, net	68,460		55,324
Inventories	65,510		52,896
Prepaid expenses and other current assets	18,927		16,246
Total current assets	257,734		230,061
Property, plant and equipment, net	49,191		54,190
Operating lease right-of-use assets	12,091		13,201
Purchased intangible assets, net	787		844
Goodwill	1,115		1,115
Other long-term assets	5,636		6,156
Total assets	$	326,554	$	305,567

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	69,685	$	58,125
Short-term borrowing, net	—		14,914
Current portion of long-term debt	2,449		2,928
Accrued and other current liabilities	29,327		30,008
Total current liabilities	101,461		105,975
Long-term debt, net of current portion	23,945		25,753
Related party long-term debt	29,954		—
Operating lease liabilities, noncurrent	12,107		13,441
Other noncurrent liabilities	6,813		7,437
Total liabilities	174,280		152,606

Stockholders’ equity:
Common stock	134		133
Additional paid-in capital	614,553		610,085
Accumulated other comprehensive income (loss)	(8,782)		2,376
Accumulated deficit	(453,631)		(459,633)
Total stockholders’ equity	152,274		152,961
Total liabilities and stockholders’ equity	$	326,554	$	305,567

NeoPhotonics Corporation

Condensed Consolidated Statement of Operations (Unaudited)

(In thousands, except percentages and per share data)


	Three Months Ended									Six Months Ended
	Jun. 30, 2022			Mar. 31, 2022			Jun. 30, 2021			Jun. 30, 2022			Jun. 30, 2021
Revenue	$	95,006		$	89,268		$	65,010		$	184,274		$	125,935
Cost of goods sold (1)	61,935			61,979			55,135			123,914			102,721
Gross profit	33,071			27,289			9,875			60,360			23,214
Gross margin	34.8		%	30.6		%	15.2		%	32.8		%	18.4		%
Operating expenses:
Research and development (1)	14,736			15,098			15,410			29,834			28,508
Sales and marketing (1)	3,742			3,686			3,362			7,428			7,227
General and administrative (1) (2)	9,228			9,794			7,398			19,022			14,692
Acquisition and asset sale related costs (recoveries)	638			905			(36)			1,543			127
Restructuring charges	—			—			22			—			22
Asset impairment charges	30			413			—			443			—
Facility shutdown related costs	209			300			—			509			—
Litigation Settlement	(12)			49			—			37			—
Gain on asset sale	(1,866)			(114)			—			(1,980)			—
Total operating expenses	26,705			30,131			26,156			56,836			50,576
Income (loss) from operations	6,366			(2,842)			(16,281)			3,524			(27,362)
Interest income	147			71			140			218			245
Interest expense	(510)			(355)			(220)			(865)			(447)
Other income (expense), net	5,823			395			(880)			6,218			263
Total interest and other income (expense), net	5,460			111			(960)			5,571			61
Income (loss) before income taxes	11,826			(2,731)			(17,241)			9,095			(27,301)
Income tax provision	(2,521)			(572)			(191)			(3,093)			(823)
Net income (loss)	$	9,305		$	(3,303)		$	(17,432)		$	6,002		$	(28,124)
Basic net income (loss) per share	$	0.17		$	(0.06)		$	(0.34)		$	0.11		$	(0.55)
Diluted net income (loss) per share	$	0.17		$	(0.06)		$	(0.34)		$	0.11		$	(0.55)
Weighted average shares used to compute basic net income (loss) per share	53,488			53,146			51,634			53,318			51,178
Weighted average shares used to compute diluted net income (loss) per share	56,095			53,146			51,634			55,999			51,178

(1) Includes stock-based compensation expense as follows for the periods presented:
Cost of goods sold	$	404		$	525		$	572		$	929		$	1,120
Research and development	794			774			744			1,568			1,606
Sales and marketing	400			385			261			785			815
General and administrative	1,011			931			763			1,942			2,076
Total stock-based compensation expense	$	2,609		$	2,615		$	2,340		$	5,224		$	5,617

(2) Includes $1,359 and $2,810 of retention costs related to the acquisition for the three and six months ended June 30, 2022, respectively.

NeoPhotonics Corporation

Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited)

(In thousands, except percentages and per share data)


	Three Months Ended									Six Months Ended
	Jun. 30, 2022			Mar. 31, 2022			Jun. 30, 2021			Jun. 30, 2022			Jun. 30, 2021
NON-GAAP GROSS PROFIT:
GAAP gross profit	$	33,071		$	27,289		$	9,875		$	60,360		$	23,214
Stock-based compensation expense	404			525			572			929			1,120
Amortization of purchased intangible assets	7			8			153			15			338
Depreciation of acquisition-related fixed asset step-up	3			3			3			6			(3)
End-of-life related inventory write-down	—			—			3,257			—			2,680
Accelerated depreciation	—			—			157			—			331
Restructuring charges (recoveries)	—			(18)			113			(18)			113
Non-GAAP gross profit	$	33,485		$	27,807		$	14,130		$	61,292		$	27,793
Non-GAAP gross margin as a % of revenue	35.2		%	31.2		%	21.7		%	33.3		%	22.1		%

NON-GAAP TOTAL OPERATING EXPENSES:
GAAP total operating expenses	$	26,705		$	30,131		$	26,156		$	56,836		$	50,576
Stock-based compensation expense	(2,205)			(2,090)			(1,768)			(4,295)			(4,497)
Depreciation of acquisition-related fixed asset step-up	(12)			(14)			(21)			(26)			(46)
Acquisition and asset sale related costs	(638)			(905)			36			(1,543)			(127)
Retention costs related to acquisition	(1,359)			(1,451)			—			(2,810)			—
Restructuring charges	—			—			(22)			—			(22)
Asset impairment charges	(30)			(413)			—			(443)			—
Facility shutdown related costs	(209)			(300)			—			(509)			—
Litigation settlement	12			(49)			—			(37)			—
Gain on asset sale	1,866			114			—			1,980			—
Non-GAAP total operating expenses	$	24,130		$	25,023		$	24,381		$	49,153		$	45,884
Non-GAAP total operating expenses as a % of revenue	25.4		%	28.0		%	37.5		%	26.7		%	36.4		%

NON-GAAP OPERATING INCOME (LOSS):
GAAP income (loss) from operations	$	6,366		$	(2,842)		$	(16,281)		$	3,524		$	(27,362)
Stock-based compensation expense	2,609			2,615			2,340			5,224			5,617
Amortization of purchased intangible assets	7			8			153			15			338
Depreciation of acquisition-related fixed asset step-up	15			17			24			32			43
Acquisition and asset sale related costs (recoveries)	638			905			(36)			1,543			127
Retention costs related to acquisition	1,359			1,451			—			2,810			—
End-of-life related inventory write-down	—			—			3,257			—			2,680
Accelerated depreciation	—			—			157			—			331
Restructuring charges (recoveries)	—			(18)			135			(18)			135
Asset impairment charges	30			413			—			443			—
Facility shutdown related costs	209			300			—			509			—
Litigation settlement	(12)			49			—			37			—
Gain on asset sale	(1,866)			(114)			—			(1,980)			—
Non-GAAP income (loss) from operations	$	9,355		$	2,784		$	(10,251)		$	12,139		$	(18,091)
Non-GAAP operating margin as a % of revenue	9.8		%	3.1		%	(15.8)		%	6.6		%	(14.4)		%

NeoPhotonics Corporation

Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Continued)

(In thousands, except percentages and per share data)


	Three Months Ended									Six Months Ended
	Jun. 30, 2022			Mar. 31, 2022			Jun. 30, 2021			Jun. 30, 2022			Jun. 30, 2021
NON-GAAP NET INCOME (LOSS):
GAAP net income (loss)	$	9,305		$	(3,303)		$	(17,433)		$	6,002		$	(28,124)
Stock-based compensation expense	2,609			2,615			2,340			5,224			5,617
Amortization of purchased intangible assets	7			8			153			15			338
Depreciation of acquisition-related fixed asset step-up	15			17			24			32			43
Acquisition and asset sale related costs (recoveries)	638			905			(36)			1,543			127
Retention costs related to acquisition	1,359			1,451			—			2,810			—
End-of-life related inventory write-down	—			—			3,257			—			2,680
Accelerated depreciation	—			—			157			—			331
Restructuring charges (recoveries)	—			(18)			135			(18)			135
Asset impairment charges	30			413			—			443			—
Facility shutdown related costs	209			300			—			509			—
Litigation settlement	(12)			49			—			37			—
Gain on asset sale	(1,866)			(114)			—			(1,980)			—
Unrealized foreign exchange (gain) loss, net (3)	(5,386)			555			(153)			(4,831)			(3,672)
Income tax effect of Non-GAAP adjustments	1,439			(83)			22			1,356			976
Non-GAAP net income (loss)	$	8,347		$	2,795		$	(11,534)		$	11,142		$	(21,549)
Non-GAAP net income (loss) as a % of revenue	8.8		%	3.1		%	(17.7)		%	6.0		%	(17.1)		%

ADJUSTED EBITDA:
GAAP net income (loss)	$	9,305		$	(3,303)		$	(17,433)		$	6,002		$	(28,124)
Stock-based compensation expense	2,609			2,615			2,340			5,224			5,617
Amortization of purchased intangible assets	7			8			153			15			338
Depreciation of acquisition-related fixed asset step-up	15			17			24			32			43
Acquisition and asset sale related costs (recoveries)	638			905			(36)			1,543			127
Retention costs related to acquisition	1,359			1,451			—			2,810			—
End-of-life related inventory write-down	—			—			3,257			—			2,680
Accelerated depreciation	—			—			157			—			331
Restructuring charges (recoveries)	—			(18)			135			(18)			135
Asset impairment charges	30			413			—			443			—
Facility shutdown related costs	209			300			—			509			—
Litigation settlement	(12)			49			—			37			—
Gain on asset sale	(1,866)			(114)			—			(1,980)			—
Unrealized foreign exchange (gain) loss, net (3)	(5,386)			555			(153)			(4,831)			(3,672)
Interest expense, net	363			284			80			647			202
Income tax provision	2,521			572			191			3,093			823
Depreciation expense	3,438			4,035			5,771			7,473			11,774
Adjusted EBITDA	$	13,230		$	7,769		$	(5,514)		$	20,999		$	(9,726)
Adjusted EBITDA as a % of revenue	13.9		%	8.7		%	(8.5)		%	11.4		%	(7.7)		%

NeoPhotonics Corporation

Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Continued)

(In thousands, except percentages and per share data)




BASIC AND DILUTED NET INCOME (LOSS) PER SHARE:
GAAP basic net income (loss) per share	$	0.17	$	(0.06)	$	(0.34)	$	0.11	$	(0.55)
GAAP diluted net income (loss) per share	$	0.17	$	(0.06)	$	(0.34)	$	0.11	$	(0.55)
Non-GAAP basic net income (loss) per share	$	0.16	$	0.05	$	(0.22)	$	0.21	$	(0.42)
Non-GAAP diluted net income (loss) per share	$	0.15	$	0.05	$	(0.22)	$	0.19	$	(0.42)

SHARES USED TO COMPUTE GAAP AND NON-GAAP BASIC NET INCOME (LOSS) PER SHARE	53,488		53,146		51,634		53,518		51,178
SHARES USED TO COMPUTE GAAP DILUTED NET INCOME (LOSS) PER SHARE	56,095		53,146		51,634		55,999		51,178
SHARES USED TO COMPUTE NON-GAAP DILUTED NET INCOME (LOSS) PER SHARE	57,307		57,344		51,634		57,327		51,178

(3) The non-GAAP financial measures for the three and six months ended June 30, 2021, and the three months ended March 31, 2022, have been adjusted to conform to the current period presentation by removing unrealized foreign exchange (gain) loss, net.

Contacts

NeoPhotonics Corporation

Beth Eby, Chief Financial Officer

+1-408-895-6086

ir@neophotonics.com

Sapphire Investor Relations, LLC

Erica Mannion, Investor Relations

+1-617-542-6180

ir@neophotonics.com

EX-101.SCH 3 nptn-20220725.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 nptn-20220725_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 nptn-20220725_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 nptnq22019logoa01.jpg begin 644 nptnq22019logoa01.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover Page	Jul. 25, 2022
Cover [Abstract]
Document Type	8-K
Document Period End Date	Jul. 25, 2022
Entity Registrant Name	NEOPHOTONICS CORP
Entity Incorporation, State or Country Code	DE
Entity File Number	001-35061
Entity Tax Identification Number	94-3253730
Entity Address, Address Line One	3081 Zanker Road
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	232-9200
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.0025 par value
Trading Symbol	NPTN
Security Exchange Name	NYSE
Entity Emerging Growth Company	false
Entity Central Index Key	0001227025
Amendment Flag	false

XML 8 nptn-20220725_htm.xml IDEA: XBRL DOCUMENT 0001227025 2022-07-25 2022-07-25 false 0001227025 8-K 2022-07-25 NEOPHOTONICS CORP DE 001-35061 94-3253730 3081 Zanker Road San Jose CA 95134 408 232-9200 false false false false Common Stock, $0.0025 par value NPTN NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.neophotonics.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports nptn-20220725.htm exhibit991_7252022.htm nptn-20220725.xsd nptn-20220725_lab.xml nptn-20220725_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nptn-20220725.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "nptn-20220725.htm" ] }, "labelLink": { "local": [ "nptn-20220725_lab.xml" ] }, "presentationLink": { "local": [ "nptn-20220725_pre.xml" ] }, "schema": { "local": [ "nptn-20220725.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nptn", "nsuri": "http://www.neophotonics.com/20220725", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nptn-20220725.htm", "contextRef": "icd0e5802277842b7aa742970a9027908_D20220725-20220725", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.neophotonics.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nptn-20220725.htm", "contextRef": "icd0e5802277842b7aa742970a9027908_D20220725-20220725", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001227025-22-000122-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001227025-22-000122-xbrl.zip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`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�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end